The Nuts & Bolts of Due Diligence in Biopharma Partnering This whitepaper focuses on best practices in due diligence with the goal of forming productive biopharma partnerships. Best Practices & Trends BioPharma Due Diligence Licensing & Partnering Life Sciences Series Whitepapers
What's Hot and What's Not in Oncology Licensing in 2020? In this whitepaper, Linda Pullan, PhD of Pullan Consulting and our panel of experts provided insights in oncology and immuno-oncology in 2020. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
How to Win at the Partnering Game In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
Preparing For Your Exit This whitepaper discusses how smart business process necessitates the organization of company information in a way that can be easily accessible and understandable to a buyer. Energy Finance Legal Life Sciences Other Industries Real Estate
Precision Medicine in Central Nervous System Drug Development Precision medicine, which has been pioneered by the field of oncology, aims to target the right treatments to the right patients at the right time. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Microbiome: Hope or Hype? This whitepaper discusses how will microbiome impact human therapeutics, who's driving it, and why. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
National Institute of Health Small Business Programs This guide reviews the description of the programs and goals, tips on applying, and resources available to researchers and small/startup businesses interested in translating their technologies into commercial products. BioPharma Life Sciences Other Topics Whitepapers
What’s Hot & What’s Not in Immuno-Oncology Licensing This whitepaper is based on two live web panels and discusses what’s exciting in immuno-oncology drug development versus what is not popular in licensing, and why. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
The Nuts & Bolts of Selecting a Contract Research Organization This whitepaper discusses how to determine internal champions/selection committees, strategic sourcing/Procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Gene & Cell Therapies This whitepaper explores the state-of-the-art, the potential and challenges ahead for advanced therapies. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Non-Immuno-Oncology and Immuno-Oncology Partnering and Development: What’s the Role of Non-IO in an IO World? This whitepaper discusses the role of non-immuno-oncology therapies for cancer in a world where immuno-oncology is playing a greater role. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
What’s Hot & What’s Not in Oncology Licensing in 2020? This whitepaper focuses on what's exciting in cancer drug development versus what is not popular in licensing, and why. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Other Topics Series Whitepapers